Zoetis Inc (NYSE:ZTS)
| 201.42 Delayed Data As of Sep 22 |  +0.41 / +0.20%Today’s Change | 141.41 Today|||52-Week Range 210.10 | +21.70% Year-to-Date |
Latest ZTS News | Press Releases
| COLL vs. ZTS: Which Stock Should Value Investors Buy Now? Sep 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 201.01 |
| Today’s open | 202.90 |
| Day’s range | 200.34 - 203.58 |
| Volume | 1,673,218 |
| Average volume (3 months) | 1,602,648 |
| Market cap | $94.1B |
Data as of 4:14pm ET, 09/22/2021
Growth & Valuation
| Earnings growth (last year) | +9.80% |
| Earnings growth (this year) | +18.34% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +6.63% |
| P/E ratio | 50.5 |
| Price/Sales | 11.87 |
| Price/Book | 25.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.21 | +0.54% |
| ---- | ||
| SNYSanofi | +0.31 | +0.64% |
| REGNRegeneron Pharmaceut... | -0.12 | -0.02% |
Data as of 4:14pm ET, 09/22/2021
Financials
| Next reporting date | October 20, 2021 |
| EPS forecast (this quarter) | $1.11 |
| Annual revenue (last year) | $6.7B |
| Annual profit (last year) | $1.6B |
| Net profit margin | 24.54% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Parsippany, New Jersey |
Forecasts
